tiprankstipranks
Trending News
More News >
ADMA Biologics (ADMA)
NASDAQ:ADMA
US Market
Advertisement

ADMA Biologics (ADMA) Ratios

Compare
2,917 Followers

ADMA Biologics Ratios

ADMA's free cash flow for Q1 2025 was $0.53. For the 2025 fiscal year, ADMA's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
6.58 5.16 6.89 6.87 7.71
Quick Ratio
3.36 1.69 2.73 2.77 3.62
Cash Ratio
1.34 1.03 2.20 1.68 2.80
Solvency Ratio
1.55 -0.10 -0.40 -0.58 -0.70
Operating Cash Flow Ratio
1.89 0.18 -1.52 -3.70 -5.11
Short-Term Operating Cash Flow Coverage
85.20 -48.35 0.00 0.00 -278.94
Net Current Asset Value
$ 214.66M$ 63.04M$ 73.91M$ 73.65M$ 34.32M
Leverage Ratios
Debt-to-Assets Ratio
0.16 0.43 0.44 0.37 0.47
Debt-to-Equity Ratio
0.22 1.05 1.02 0.73 1.11
Debt-to-Capital Ratio
0.18 0.51 0.50 0.42 0.53
Long-Term Debt-to-Capital Ratio
0.18 0.49 0.48 0.40 0.51
Financial Leverage Ratio
1.37 2.43 2.29 1.96 2.35
Debt Service Coverage Ratio
23.93 0.21 -3.06 -5.07 -5.80
Interest Coverage Ratio
18.57 0.86 -2.04 -4.47 -5.42
Debt to Market Cap
0.02 0.13 0.19 0.48 0.56
Interest Debt Per Share
0.38 0.74 0.88 0.83 1.27
Net Debt to EBITDA
0.07 17.59 -1.71 -0.97 -0.70
Profitability Margins
Gross Profit Margin
52.55%34.44%22.89%1.45%-45.17%
EBIT Margin
25.57%-1.24%-30.26%-72.39%-151.03%
EBITDA Margin
34.46%1.98%-25.78%-65.89%-141.69%
Operating Profit Margin
33.10%8.38%-25.55%-72.12%-153.75%
Pretax Profit Margin
30.64%-10.94%-42.77%-88.52%-179.41%
Net Profit Margin
45.01%-10.94%-55.29%-104.34%-207.50%
Continuous Operations Profit Margin
39.15%-10.94%-42.77%-88.52%-179.41%
Net Income Per EBT
146.89%100.00%129.25%117.87%115.65%
EBT Per EBIT
92.58%-130.54%167.42%122.74%116.69%
Return on Assets (ROA)
40.50%-8.58%-24.45%-30.57%-42.18%
Return on Equity (ROE)
72.39%-20.89%-56.05%-59.82%-99.27%
Return on Capital Employed (ROCE)
33.26%7.74%-12.73%-23.74%-34.58%
Return on Invested Capital (ROIC)
48.74%7.72%-16.41%-27.92%-39.84%
Return on Tangible Assets
40.82%-8.68%-24.77%-31.16%-43.43%
Earnings Yield
4.84%-2.79%-11.10%-42.91%-52.15%
Efficiency Ratios
Receivables Turnover
4.62 9.42 9.94 2.83 3.19
Payables Turnover
10.58 10.81 8.98 6.42 5.53
Inventory Turnover
1.27 0.98 0.73 0.64 0.75
Fixed Asset Turnover
7.96 4.07 2.24 1.39 0.92
Asset Turnover
0.90 0.78 0.44 0.29 0.20
Working Capital Turnover Ratio
1.60 1.18 0.75 0.52 0.41
Cash Conversion Cycle
332.80 377.83 497.69 642.69 534.05
Days of Sales Outstanding
78.99 38.76 36.73 128.86 114.44
Days of Inventory Outstanding
288.32 372.83 501.60 570.70 485.56
Days of Payables Outstanding
34.51 33.77 40.64 56.87 65.95
Operating Cycle
367.31 411.59 538.33 699.56 600.00
Cash Flow Ratios
Operating Cash Flow Per Share
0.43 0.04 -0.30 -0.81 -1.18
Free Cash Flow Per Share
0.38 0.02 -0.37 -0.90 -1.33
CapEx Per Share
0.04 0.02 0.07 0.10 0.15
Free Cash Flow to Operating Cash Flow
0.90 0.43 1.23 1.12 1.12
Dividend Paid and CapEx Coverage Ratio
9.59 1.77 -4.28 -8.32 -8.01
Capital Expenditure Coverage Ratio
9.59 1.77 -4.28 -8.32 -8.01
Operating Cash Flow Coverage Ratio
1.23 0.06 -0.39 -1.09 -1.04
Operating Cash Flow to Sales Ratio
0.22 0.03 -0.39 -1.39 -2.42
Free Cash Flow Yield
2.11%0.38%-9.56%-63.96%-68.30%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
20.72 -35.85 -9.01 -2.33 -1.92
Price-to-Sales (P/S) Ratio
9.36 3.92 4.98 2.43 3.98
Price-to-Book (P/B) Ratio
11.47 7.49 5.05 1.39 1.90
Price-to-Free Cash Flow (P/FCF) Ratio
47.44 265.09 -10.46 -1.56 -1.46
Price-to-Operating Cash Flow Ratio
42.32 115.04 -12.90 -1.75 -1.65
Price-to-Earnings Growth (PEG) Ratio
5.80 0.51 0.31 0.06 0.67
Price-to-Fair Value
11.47 7.49 5.05 1.39 1.90
Enterprise Value Multiple
27.24 215.32 -21.04 -4.66 -3.51
Enterprise Value
4.30B 1.10B 835.68M 248.64M 209.73M
EV to EBITDA
27.18 215.32 -21.04 -4.66 -3.51
EV to Sales
9.37 4.27 5.42 3.07 4.97
EV to Free Cash Flow
47.46 288.67 -11.38 -1.98 -1.83
EV to Operating Cash Flow
42.51 125.28 -14.04 -2.21 -2.06
Tangible Book Value Per Share
1.55 0.59 0.75 0.97 0.96
Shareholders’ Equity Per Share
1.57 0.60 0.77 1.01 1.02
Tax and Other Ratios
Effective Tax Rate
-0.47 0.00 -0.29 -0.18 -0.16
Revenue Per Share
1.93 1.15 0.78 0.58 0.49
Net Income Per Share
0.87 -0.13 -0.43 -0.61 -1.02
Tax Burden
1.47 1.00 1.29 1.18 1.16
Interest Burden
1.20 8.79 1.41 1.22 1.19
Research & Development to Revenue
<0.01 0.01 0.02 0.05 0.14
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.04 0.02 0.03 0.04 0.07
Income Quality
0.49 -0.31 0.90 1.57 1.35
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis